{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:47:57Z","timestamp":1753876077304,"version":"3.41.2"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T00:00:00Z","timestamp":1672099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Barrett\u2019s esophagus (BE) occurs in 5\u201315% of patients with gastroesophageal reflux disease (GERD). While acid suppressive therapy is a critical component of BE management to minimize the risk of progression to esophageal adenocarcinoma, surgical control of mechanical reflux is sometimes necessary. Magnetic sphincter augmentation (MSA) is an increasingly utilized anti-reflux surgical therapy for GERD. While the use of MSA is listed as a precaution by the United States Food and Drug Administration, there are limited data showing effective BE regression with MSA. MSA offers several advantages in BE including effective reflux control, anti-reflux barrier restoration and reduced hiatal hernia recurrence. However, careful patient selection for MSA is necessary.<\/jats:p>","DOI":"10.1093\/dote\/doac096","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T08:53:29Z","timestamp":1672217609000},"source":"Crossref","is-referenced-by-count":0,"title":["Magnetic sphincter augmentation: considerations for use in Barrett\u2019s esophagus"],"prefix":"10.1093","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9530-2233","authenticated-orcid":false,"given":"Audra J","family":"Reiter","sequence":"first","affiliation":[{"name":"Northwestern University Department of Surgery, Feinberg School of Medicine, , Chicago, IL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico A","family":"Farina","sequence":"additional","affiliation":[{"name":"Northwestern University Department of Gastroenterology, Feinberg School of Medicine, , Chicago, IL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey S","family":"Fronza","sequence":"additional","affiliation":[{"name":"Northwestern University Department of Surgery, Feinberg School of Medicine, , Chicago, IL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinadh","family":"Komanduri","sequence":"additional","affiliation":[{"name":"Northwestern University Department of Gastroenterology, Feinberg School of Medicine, , Chicago, IL , USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,12,27]]},"reference":[{"issue":"2","key":"2023062314435493600_ref1","first-page":"267","article-title":"Presentation and epidemiology of gastroesophageal reflux disease","volume":"154","author":"Richter","year":"2018","journal-title":"Gastroenterol (New York, NY 1943)"},{"issue":"1","key":"2023062314435493600_ref2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1365-2036.2011.04901.x","article-title":"Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care - The ProGERD study","volume":"35","author":"Malfertheiner","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"2023062314435493600_ref3","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.cgh.2019.08.056","article-title":"Magnetic sphincter augmentation superior to proton pump inhibitors for regurgitation in a 1-year randomized trial","volume":"18","author":"Bell","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2023062314435493600_ref4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s13304-018-0569-6","article-title":"Magnetic sphincter augmentation for gastroesophageal reflux disease: review of clinical studies","volume":"3","author":"Asti","year":"2018","journal-title":"Updates Surg"},{"key":"2023062314435493600_ref5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jamcollsurg.2015.02.025","article-title":"Laparoscopic magnetic sphincter augmentation vs laparoscopic nissen fundoplication: a matched-pair analysis of 100 patients","volume":"221","author":"JLM","year":"2015","journal-title":"J Am Coll Surg"},{"issue":"10","key":"2023062314435493600_ref6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1089\/lap.2015.0394","article-title":"Magnetic sphincter augmentation for gastroesophageal reflux at 5 years: final results of a pilot study show long-term acid reduction and symptom improvement","volume":"25","author":"Saino","year":"2015","journal-title":"J Laparoendosc Adv Surg Tech"},{"key":"2023062314435493600_ref7","first-page":"671","article-title":"Long-term outcomes of patients receiving a magnetic sphincter augmentation device for gastroesophageal reflux","volume":"5","author":"Ganz","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"2023062314435493600_ref8","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1007\/s00464-015-4659-y","article-title":"Multi-institutional outcomes using magnetic sphincter augmentation versus Nissen fundoplication for chronic gastroesophageal reflux disease","volume":"30","author":"Warren","year":"2016","journal-title":"Surg Endosc"},{"issue":"2","key":"2023062314435493600_ref9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.gtc.2015.02.001","article-title":"Epidemiology of Barrett\u2019s esophagus and esophageal adenocarcinoma","volume":"44","author":"Runge","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"issue":"15","key":"2023062314435493600_ref10","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJMoa1103042","article-title":"Incidence of adenocarcinoma among patients with Barrett\u2019s esophagus","volume":"365","author":"Hvid-Jensen","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"2023062314435493600_ref11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bpg.2014.11.009","article-title":"Risk factors and populations at risk: selection of patients for screening for Barrett\u2019s oesophagus","volume":"29","author":"Rubenstein","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2023062314435493600_ref12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.giec.2020.08.001","article-title":"Epidemiology of Barrett\u2019s esophagus and esophageal adenocarcinoma","volume":"31","author":"Cook","year":"2021","journal-title":"Gastrointest Endosc Clin N Am"},{"issue":"6","key":"2023062314435493600_ref13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.surge.2015.01.001","article-title":"Surgical and endoscopic management of high grade dysplasia and early oesophageal adenocarcinoma","volume":"14","author":"Le Page","year":"2016","journal-title":"Surgeon"},{"key":"2023062314435493600_ref14","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.2147\/DDDT.S306371","article-title":"Pharmacological management of gastro-esophageal reflux disease: an update of the state-of-the-art","volume":"15","author":"Savarino","year":"2021","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"2023062314435493600_ref15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.cgh.2019.07.015","article-title":"Phenotypes of gastroesophageal reflux disease: where rome, lyon, and montreal meet","volume":"18","author":"Katzka","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"2023062314435493600_ref16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/MOG.0000000000000084","article-title":"Risk factors for Barrett\u2019s esophagus","volume":"30","author":"Rubenstein","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"issue":"1","key":"2023062314435493600_ref17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2007.04.046","article-title":"Abdominal obesity and body mass index as risk factors for Barrett\u2019s esophagus","volume":"133","author":"Corley","year":"2007","journal-title":"Gastroenterology"},{"issue":"5","key":"2023062314435493600_ref18","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1053\/gast.1996.v111.pm8898632","article-title":"Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease","volume":"111","author":"Vaezi","year":"1996","journal-title":"Gastroenterology"},{"issue":"1","key":"2023062314435493600_ref19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bpg.2014.11.002","article-title":"Mechanisms of Barrett\u2019s oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects","volume":"29","author":"Roman","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"5","key":"2023062314435493600_ref20","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1572-0241.1998.211_a.x","article-title":"Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett\u2019s esophagus","volume":"93","author":"Ouatu-Lascar","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"2023062314435493600_ref21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.giec.2019.12.002","article-title":"Personalized approach in the work-up and management of gastroesophageal reflux disease","volume":"30","author":"Yadlapati","year":"2020","journal-title":"Gastrointest Endosc Clin N Am"},{"issue":"12","key":"2023062314435493600_ref22","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.14022","article-title":"Mucosal pathogenesis in gastro-esophageal reflux disease","volume":"32","author":"Ustaoglu","year":"2020","journal-title":"Neurogastroenterol Motil"},{"issue":"4","key":"2023062314435493600_ref23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.gtc.2008.09.009","article-title":"The pathophysiologic basis for epidemiologic trends in gastroesophageal reflux disease","volume":"37","author":"Pandolfino","year":"2008","journal-title":"Gastroenterol Clin North Am"},{"issue":"1\u20132","key":"2023062314435493600_ref24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000357184","article-title":"Does Barrett\u2019s esophagus regress after surgery (or proton pump inhibitors)?","volume":"32","author":"Spechler","year":"2014","journal-title":"Dig Dis"},{"issue":"3","key":"2023062314435493600_ref25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/aje\/kwn121","article-title":"The incidence of esophageal cancer and high-grade dysplasia in Barrett\u2019s esophagus: a systematic review and meta-analysis","volume":"168","author":"Yousef","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"11","key":"2023062314435493600_ref26","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1136\/gutjnl-2019-318260","article-title":"How to select patients for antireflux surgery? The ICARUS guidelines (international consensus regarding preoperative examinations and clinical characteristics assessment to select adult patients for antireflux surgery)","volume":"68","author":"Pauwels","year":"2019","journal-title":"Gut"},{"issue":"2","key":"2023062314435493600_ref27","first-page":"1384","article-title":"Bile acids but not acidic acids induce Barrett\u2019s esophagus","volume":"8","author":"Sun","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"2023062314435493600_ref28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1001\/archsurg.139.5.547","article-title":"Persistent acid and bile reflux in asymptomatic patients with barrett esophagus receiving proton pump inhibitor therapy","volume":"139","author":"Sarela","year":"2004","journal-title":"Arch Surg"},{"key":"2023062314435493600_ref29","volume-title":"Current Surgical Therapy","author":"Cameron","year":"2020","edition":"13th"},{"journal-title":"Ethicon","article-title":"Reflux Management","author":"LINX\u00ae Procedure","key":"2023062314435493600_ref30"},{"key":"2023062314435493600_ref31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jamcollsurg.2013.04.039","article-title":"One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center","volume":"217","author":"Bonavina","year":"2013","journal-title":"J Am Coll Surg"},{"issue":"8","key":"2023062314435493600_ref32","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJMoa1205544","article-title":"Esophageal sphincter device for gastroesophageal reflux disease","volume":"368","author":"Ganz","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"2023062314435493600_ref33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.gie.2018.07.007","article-title":"Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial","volume":"89","author":"Bell","year":"2019","journal-title":"Gastrointest Endosc"},{"issue":"12","key":"2023062314435493600_ref34","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/1751-2980.13063","article-title":"Magnetic sphincter augmentation in treating refractory gastroesophageal reflux disease: a systematic review and meta-analysis","volume":"22","author":"Zhuang","year":"2021","journal-title":"J Dig Dis"},{"issue":"10","key":"2023062314435493600_ref35","doi-asserted-by":"crossref","first-page":"5607","DOI":"10.1007\/s00464-020-08063-9","article-title":"Magnetic sphincter augmentation with hiatal hernia repair: long term outcomes","volume":"35","author":"Dunn","year":"2021","journal-title":"Surg Endosc"},{"issue":"10","key":"2023062314435493600_ref49","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1007\/s00268-018-4608-8","article-title":"Results of magnetic sphincter augmentation for gastroesophageal reflux disease","volume":"42","author":"Schwameis","year":"2018","journal-title":"World J Surg"},{"issue":"2","key":"2023062314435493600_ref43","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00464-018-6367-x","article-title":"Regression of intestinal metaplasia following magnetic sphincter augmentation device placement","volume":"33","author":"Alicuben","year":"2019","journal-title":"Surg Endosc"},{"issue":"10","key":"2023062314435493600_ref42","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1007\/s00464-020-08074-6","article-title":"Regression of Barrett\u2019s esophagus after magnetic sphincter augmentation: intermediate-term results","volume":"35","author":"Dunn","year":"2021","journal-title":"Surg Endosc"},{"journal-title":"Study Results","key":"2023062314435493600_ref36","article-title":"LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve Gastrectomy"},{"key":"2023062314435493600_ref37","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1072-7515(00)00260-X","article-title":"Laparoscopic repair of large type III hiatal hernia: objective followup reveals high recurrence rate","volume":"190","author":"Hashemi","year":"2000","journal-title":"J Am Coll Surg"},{"issue":"4","key":"2023062314435493600_ref38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jamcollsurg.2011.05.017","article-title":"Biologic prosthesis to prevent recurrence after laparoscopic paraesophageal hernia repair: long-term follow-up from a multicenter, prospective, randomized trial","volume":"213","author":"Oelschlager","year":"2011","journal-title":"J Am Coll Surg"},{"issue":"8","key":"2023062314435493600_ref39","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1053\/j.gastro.2018.02.022","article-title":"The effect of endoscopic surveillance in patients with Barrett\u2019s esophagus: a systematic review and meta-analysis","volume":"154","author":"Codipilly","year":"2018","journal-title":"Gastroenterology"},{"issue":"7","key":"2023062314435493600_ref40","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/MEG.0b013e3282f8295d","article-title":"Quality of Barrett\u2019s surveillance in The Netherlands: a standardized review of endoscopy and pathology reports","volume":"20","author":"Curvers","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"volume-title":"Linx Reflux Management System: Instructions for Use","year":"2012","key":"2023062314435493600_ref41"},{"issue":"1","key":"2023062314435493600_ref44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cgh.2018.05.042","article-title":"Factors associated with recurrence of Barrett\u2019s esophagus after radiofrequency ablation","volume":"17","author":"Tan","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"2023062314435493600_ref45","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1053\/j.gastro.2017.12.045","article-title":"Controversies in endoscopic eradication therapy for Barrett\u2019s esophagus","volume":"154","author":"Komanduri","year":"2018","journal-title":"Gastroenterology"},{"issue":"4","key":"2023062314435493600_ref46","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ajg.2017.13","article-title":"Recurrence of Barrett\u2019s esophagus is rare following endoscopic eradication therapy coupled with effective reflux control","volume":"112","author":"Komanduri","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"2023062314435493600_ref47","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.gie.2016.02.009","article-title":"Risk of recurrence of Barrett\u2019s esophagus after successful endoscopic therapy","volume":"83","author":"Krishnamoorthi","year":"2016","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"2023062314435493600_ref48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1442-2050.2011.01227.x","article-title":"Low levels of adherence with proton pump inhibitor therapy contribute to therapeutic failure in gastroesophageal reflux disease","volume":"25","author":"Dal-Paz","year":"2012","journal-title":"Dis Esophagus Off J Int Soc Dis Esophagus"}],"container-title":["Diseases of the Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/36\/Supplement_1\/doac096\/50685511\/doac096.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/dote\/article-pdf\/36\/Supplement_1\/doac096\/50685511\/doac096.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T22:25:37Z","timestamp":1687645537000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/dote\/article\/doi\/10.1093\/dote\/doac096\/6961586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,27]]},"references-count":49,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2022,12,27]]},"published-print":{"date-parts":[[2023,6,15]]}},"URL":"https:\/\/doi.org\/10.1093\/dote\/doac096","relation":{},"ISSN":["1120-8694","1442-2050"],"issn-type":[{"type":"print","value":"1120-8694"},{"type":"electronic","value":"1442-2050"}],"subject":[],"published-other":{"date-parts":[[2023,6]]},"published":{"date-parts":[[2022,12,27]]},"article-number":"doac096"}}